GLP-1 Receptor Agonist

How common are Ozempic side effects?

Direct Answer

The most frequent side effects of Ozempic are gastrointestinal: nausea (up to 20%), diarrhea (8-9%), vomiting (5-9%), and constipation (3-5%). These are most intense during the first 4-8 weeks as the dose is increased, and they improve for most people as the body adjusts. Serious side effects like pancreatitis are rare (less than 1%). The side effects are a direct result of how the drug works — slowing stomach emptying is what causes both the appetite suppression and the nausea.

Based on published clinical trial data and FDA prescribing information. This is not medical advice — always consult your healthcare provider.

Supporting Evidence

Side Effects

Nausea20%
Diarrhea15%
Vomiting10%
Constipation11%
Stomach pain / cramping9%

Serious (rare)

  • Pancreatitis (<1%)
  • Kidney failure
  • Gallbladder disease

Clinical Trials

Expected HbA1c reduction: −1.5% to −1.8% from baseline (SUSTAIN trials, 0.5–2mg). Weight loss: −9–14 lbs. Wegovy (2.4mg/wk): −14.9% body weight (STEP-1). Lifestyle comparison: dietary intervention alone reduces diabetes risk by 58% (DPP trial). Oral semaglutide (OW3 9mg): −1.5–1.7% HbA1c in phase 3 trials.

Funding transparency: STEP trials and most published semaglutide research were funded by Novo Nordisk, which reported approximately $38.6B in semaglutide revenue in 2023. Lead investigators received advisory board fees, co See full funding details

Read the complete Ozempic® / Wegovy® / Rybelsus® guide

Side effect rates, clinical trial data, funding transparency, drug interactions, tapering protocols, and lifestyle alternatives — all in one place.

View Ozempic® / Wegovy® / Rybelsus®